CaPO4 blasted implants inserted into iliac crest homologue frozen grafts.

In the last decade, some investigations have reported that the resorbable blast media surface (also named CaPO4 blasted implants [CaPO4-Bls]) has achieved excellent results. However, no report regarding CaPO4-Bls inserted into fresh frozen bone (FFB) is available. Thus, we planned a retrospective study on a series of CaPO4-Bls inserted into FFB to evaluate their clinical outcome. In the period between December 2003 and December 2006, 16 patients (10 females and 6 males, median age of 55 years) were operated on, and 76 CaPO4-Bls were inserted. The mean implant follow-up was 23 months. Implant diameter and length ranged from 3.25 to 4.5 mm and from 11.5 to 15 mm, respectively. Implants were inserted to replace 7 incisors, 11 cuspids, 31 premolars, and 27 molars. Only 1 out of 76 implants was lost (i.e., survival rate [SVR] = 98.7%), and no differences were detected among the studied variables. When peri-implant crestal bone resorption was used as an indicator of clinical success (i.e., success rate), it was possible to identify some variables that correlated with a better clinical outcome. Specifically, Cox regression showed that removable prosthetic restoration and longer implant length correlated with a statistically significant lower delta implant abutment junction (IAJ; i.e., reduced crestal bone loss) and thus a better clinical outcome. In this study, CaPO4-Bls had high survival and success rates, similar to those reported in previous reports of 2-stage procedures in nongrafted bone. CaPO4-Bls inserted into FFB are reliable devices, although greater marginal bone loss occurs when fixed prosthetic restorations and short implants are used.

A 2-year follow-up study on standard length implants inserted into alveolar bone sites augmented with homografts.

OBJECTIVE: In the last decade, several investigators have reported that standard length implants (SLIs) have achieved excellent results but no report regarding SLIs (i.e. SLI, length=13 mm) inserted into alveolar bone sites previously augmented with frozen bone (FB) is available. The aim of this study was to evaluate the clinical outcome of SLIs inserted into alveolar bone sites previously augmented with FB. PATIENTS AND METHODS: The survival and success rate of standard dental implants was evaluated after surgical placement into alveolar bone sites previously augmented with FB. The distance between Implant Abutment Junction and crestal bone level (i.e. delta IAJ) was measured to evaluate the peri-implant bone loss over time. Kaplan-Meier algorithm and Cox regression were used. RESULTS: The implant survival rate was 97.6% and no differences were detected among the studied variables by using implant loss. On the contrary, the Cox regression showed that implant surface (i.e. sandblasted and acid-etched-SLA- and CaPO(4)ceramic-blasted implants, p=0.0037), graft site (i.e. maxilla, p=0.0438) and prosthetic restoration (i.e. removable dentures, p=0.0003) correlated with a statistically significant reduced crestal bone loss (i.e. success rate). CONCLUSION: SLIs had a high survival and success rate similar to those reported in previous studies of two-stage procedures in non-grafted bone. FB is a reliable material for alveolar reconstruction and implant insertion.

Implants inserted in fresh-frozen bone: a retrospective analysis of 88 implants loaded 4 months after insertion.

OBJECTIVE: In the previous decade, several reports have been published regarding implants inserted in autografts, but none have analyzed implants inserted in fresh-frozen bone allografts. Thus, a retrospective study was planned to verify if 4-months' delay from grafting to implant insertion is a safe period before prosthetic rehabilitation of implants placed in fresh-frozen bone allografts. METHOD AND MATERIALS: Between December 2003 and December 2006, 22 patients (10 women and 12 men with a median age of 51 years) underwent grafting with horizontal augmentation without membrane and 88 implants inserted thereafter. The mean implant follow-up was 27 months. Implants used were 30 double etched (3i, Osseotite, Biomet), 10 SLA1 (Astratech), 26 anodic oxidized (Nobel Biocare), 12 CaPO4 ceramic-blasted (Lifecore Biomedical), 7 SLA2 (Sweden and Martina Spa), 2 ITI (Straumann), and 1 Biotec (Povolaro di Dueville). Implant diameter and length ranged from 3.25 to 5.0 mm and from 8.0 to 15.0 mm, respectively. Implants were inserted to replace 10 incisors, 7 canines, 36 premolars, and 35 molars. RESULTS: No implants were lost (ie, survival rate = 100%). No difference was detected when comparing implants loaded after 4 months versus those loaded after 6 or more months (209 implants). CONCLUSION: Four-months' delay from grafting to implant insertion is a safe period to obtain a high survival rate and success rate for implants inserted in fresh-frozen bone.